From: Nurse-led interventions in systemic autoimmune rheumatic diseases: a systematic review
Author, year, country | SARD | Sample size | Sample characteristics | ||||
---|---|---|---|---|---|---|---|
Age Mean (SD) | Female N (%) | Race/ethnicity N (%) | Marital status N (%) | Disease duration Mean (SD) | |||
Kankaya & Karadakovan (2020); Turkey | SLE | Total = 80 Control = 40 Intervention = 40 | Control: 39.0 (12.7) Intervention: 35.6 (8.4) | Control: 38 (95%) Intervention: 38 (95%) | N/S | N/S | Control:✝ < 1 yrs: 2 (5%) 1–10 yrs: 21 (52.5%) 11–20 yrs: 13 (32.5%) > 20 yrs: 4 (10%) Intervention:✝ < 1 yrs: 3 (7.5%) 1–10 yrs: 23 (57.5%) 11–20 yrs: 11 (27.5%) > 20 yrs: 3 (7.5%) |
Karlson et al. (2004); US | SLE | Total = 122 Control = 58 Intervention = 64 | Control: 40.8 (11.1) Intervention: 42.7 (22.8) | Control: 56 (98%) Intervention: 63 (98%) | White: Control: 48 (84%) Intervention: 57 (89%) | N/S | N/S |
Uras et al. (2019); Italy | Systemic sclerosis | Total = 63 Control = 31 Intervention = 32 | Control: 55.2 (13.3) Intervention: 54.6 (15.8) | 100% | N/S | Control: 18 (58.1%) Intervention: 21 (65.6%) | Control: 11.8 yrs (8.4) Intervention: 8.7 yrs (6.3) |
Wu et al. (2018); Taiwan | SLE | Total = 76 Control = 38 Intervention = 38 | Control: 43.5 (12.7) Intervention: 43.8 (9.9) | 100% | N/S | Control: 22 (57.9%) Intervention: 29 (76.3%) | Control: 12.3 yrs (8.4) Intervention: 12.0 yrs (7.4) |
Xie et al. (2018); China | SLE | Total = 125 Control = 61 Intervention = 64 | Control: 38.4 (15.8) Intervention: 35.9 (12.3) | Control: 54 (88.5%) Intervention: 57 (89.1%) | N/S | Control: 47 (77%) Intervention: 45 (70.3%) | Control: ≤ 3 yrs = 30 (49.2) > 3 yrs = 31 (50.8) Intervention: ≤ 3 yrs = 33 (51.6) > 3 yrs = 31 (48.4) |